Natan Ponieman - Spark Newswire

2 minute read

Dutchie: First Cannabis E-Commerce Platform To Receive Approval In Ontario Via Canopy Growth Partnership

Today, 9:32 AM

Dutchie announced on Thursday that its e-commerce solution has passed an audit by the Alcohol and Gaming Commission of Ontario (AGCO), making it the first e-commerce platform in the country to receive this sort of approval.

CGC

3 minute read

The Legacy Of Dr. Aaron Beck, Father Of Cognitive Therapy, Lives On In Psychedelic Medicine

By Natan Ponieman

Today, 9:32 AM

Dr. Aaron T. Beck, the father of cognitive therapy, died on Monday at his home in Philadelphia at age 100.

CSE:WESA

6 minute read

Psyched: MindMed’s MDMA Program For Autism, Small Pharma’s New Patent, NovaMentis’ Orphan Drug Designation

By Natan Ponieman

Today, 9:32 AM

The Week In Psychedelics: MindMed Launches MDMA Program For Social Anxiety And Autism

AWKNF

2 minute read

Will Hexo’s New CEO Help The Cannabis Giant Pivot Towards Positive EBITDA?

By Natan Ponieman

Today, 9:32 AM

Financial analysis firm Cantor Fitzgerald issued a new report on Canadian cannabis LP Hexo Corp.

HEXO

3 minute read

U.S. Cannabis Industry is ‘Flourishing’ In Spite Of (Or Because Of?) General Economic Downturn

By Natan Ponieman

Today, 9:32 AM

While the cannabis industry is known for offering investors its own mixture of tricks and treats, a new report by CNN Business is expressing new hope for the cannabis sector.

NFLX

5 minute read

Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent

By Natan Ponieman

Today, 9:32 AM

The Week In Psychedelics British Prime Minister Boris Johnson To Consider Psilocybin Legalization

AWKNF

2 minute read

Stellantis Auto Maker To Include Two Cannabis Companies In Development Program For Black Businesses

By Natan Ponieman

Today, 9:32 AM

One World Pharma (OTCQB: OWPC), a Las Vegas-based cannabis producer with grow operations in Colombia, and Isiah International are among the 13 businesses to have been selected to participate in the pilot for a development program conducted by the National Business League (NBL) and automaker Stellanti

OWPC

1 minute read

Phase 2 Trial On Ayahuasca’s Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race

By Natan Ponieman

Today, 9:32 AM

Small Pharma Inc. (OTCQB: DMTTF) (TSXV: DMT), a biotech company focused on psychedelic therapies, has begun its phase 2a clinical trial on SPL026.

CMPS

1 minute read

Psychedelic Unicorn Compass Pathways Receives New Patent Approval

By Natan Ponieman

Today, 9:32 AM

Compass Pathways (NASDAQ: CMPS), a unicorn company in the psychedelics space, has been granted its fourth patent by the US Patent and Trademark Office.

CMPS

1 minute read

Historic: Federal Agency Awards Grant For Psychedelics Research, First Time In 50 years

By Natan Ponieman

Today, 9:32 AM

The National Institutes of Health awarded a nearly $4 million grant meant to fund research on psilocybin, the active ingredient in “magic mushrooms,” to researchers at Johns Hopkins University.

MYCOF